Literature DB >> 6090954

An artefact explains the apparent association of the transferrin receptor with a ras gene product.

J Harford.   

Abstract

There is substantial evidence implicating ras genes in a number of human neoplasms. The ras genes of several human tumours display mutational changes which are likely to be responsible for their transforming activity. Normal cells also express ras genes, over-expression of which can induce cellular transformation. ras genes encode proteins of approximately 21,000 molecular weight (MW) (p21) that are localized to the inner surface of the plasma membrane. Much effort is being focused on the elucidation of the physiological function of ras-encoded proteins in normal and transformed cells, concentrating on interactions between p21 and other cellular elements. Recently, Finkel and Cooper reported that p21 in extracts of human bladder carcinoma cells is involved in a molecular complex with the transferrin receptor of these cells. This report aroused considerable interest, particularly as expression of the transferrin receptor has been linked to cell proliferation. I present here evidence that the apparent association of p21 and the transferrin receptor is an artefact of the immunoprecipitation technique.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090954     DOI: 10.1038/311673a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  3 in total

Review 1.  The long history of iron in the Universe and in health and disease.

Authors:  Alex D Sheftel; Anne B Mason; Prem Ponka
Journal:  Biochim Biophys Acta       Date:  2011-08-09

2.  Binding of proteins, including pp60src, to activated CH-sepharose 4B.

Authors:  N Pavloff; J M Biquard; M Mariller; G C Rabotti; N Fossar; F Gay; M Semmel
Journal:  Mol Biol Rep       Date:  1987       Impact factor: 2.316

3.  Two genetic loci participate in the regulation by iron of the gene for the human transferrin receptor.

Authors:  J L Casey; B Di Jeso; K Rao; R D Klausner; J B Harford
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.